Finance

Beta
Lists
4BB:LON
4Basebio PLC
GBX 550.00
+4.76%
(+25.00) 1D
Jun 19, 4:35:02 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for 4BB...
Open
GBX 524.40
High
GBX 550.00
Low
GBX 501.00
Mkt. cap
85.46M
Avg. vol.
1.99K
Volume
0.00
52-wk high
GBX 1,040.00
52-wk low
GBX 420.00
EPS
-GBX 1.09
Shares outstanding
15.54M
No. of employees
140
Open
GBX 524.40
High
GBX 550.00
Low
GBX 501.00
Mkt. cap
85.46M
Avg. vol.
1.99K
Volume
0.00
52-wk high
GBX 1,040.00
52-wk low
GBX 420.00
EPS
-GBX 1.09
Shares outstanding
15.54M
No. of employees
140
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to 4BB in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for 4BB in the last 3 months.
Highest
Current GBX 550.00
GBX 1,400.00 (+154.55%)
Average
GBX 1,400.00 (+154.55%)
Lowest
GBX 1,400.00 (+154.55%)
News stories
From sources across the web
About 4Basebio PLC
CEO-
Employees140
Founded2008
Headquarters-
SectorBiotechnology
Website4basebio.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
587.00K
587.00K
259.50K
259.50K
Cost of goods sold
236.50K
236.50K
123.00K
123.00K
Cost of revenue
236.50K
236.50K
123.00K
123.00K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.47M
4.47M
4.38M
4.38M
Operating expense
4.52M
4.52M
4.30M
4.30M
Total operating expenses
4.76M
4.76M
4.42M
4.42M
Operating income
-4.17M
-4.17M
-4.16M
-4.16M
Other non operating income
-
-
-
-
EBT including unusual items
-4.11M
-4.11M
-4.69M
-4.69M
EBT excluding unusual items
-4.11M
-4.11M
-4.69M
-4.69M
Income tax expense
-209.00K
-209.00K
-140.00K
-140.00K
Effective tax rate
5.08%
5.08%
2.98%
2.98%
Other operating expenses
53.50K
53.50K
-85.00K
-85.00K
Net income
-3.90M
-3.90M
-4.55M
-4.55M
Net profit margin
-664.74%
-664.74%
-1,753.56%
-1,753.56%
Earnings per share
-
-
-
-
Interest and investment income
266.00K
266.00K
176.00K
176.00K
Interest expense
-208.00K
-208.00K
-235.50K
-235.50K
Net interest expenses
58.00K
58.00K
-59.50K
-59.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.97M
-3.97M
-3.90M
-3.90M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer